These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29883239)

  • 1. Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?
    Agarwal P; Agarwal R
    Expert Opin Ther Targets; 2018 Jul; 22(7):629-638. PubMed ID: 29883239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in targeting the extracellular matrix for glaucoma therapy: current updates.
    Agarwal R; Iezhitsa I
    Expert Opin Ther Targets; 2023; 27(12):1217-1229. PubMed ID: 38069479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure-induced expression changes in segmental flow regions of the human trabecular meshwork.
    Vranka JA; Acott TS
    Exp Eye Res; 2017 May; 158():67-72. PubMed ID: 27334250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The exit strategy: Pharmacological modulation of extracellular matrix production and deposition for better aqueous humor drainage.
    Pattabiraman PP; Toris CB
    Eur J Pharmacol; 2016 Sep; 787():32-42. PubMed ID: 27112663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma.
    Vranka JA; Kelley MJ; Acott TS; Keller KE
    Exp Eye Res; 2015 Apr; 133():112-25. PubMed ID: 25819459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma.
    Kasetti RB; Maddineni P; Kodati B; Nagarajan B; Yacoub S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to play.
    Agarwal R; Agarwal P
    Ophthalmic Res; 2010; 43(1):1-10. PubMed ID: 19829006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review.
    Keller KE; Peters DM
    Clin Exp Ophthalmol; 2022 Mar; 50(2):163-182. PubMed ID: 35037377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstructing aqueous humor outflow - The last 50 years.
    Kaufman PL
    Exp Eye Res; 2020 Aug; 197():108105. PubMed ID: 32590004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Salidroside on Trabecular Meshwork Cell Extracellular Matrix Expression and Mouse Intraocular Pressure.
    Fan Y; Guo L; Wei J; Chen J; Sun H; Guo T
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2072-2082. PubMed ID: 31091314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk Between Transforming Growth Factor Beta-2 and Toll-Like Receptor 4 in the Trabecular Meshwork.
    Hernandez H; Medina-Ortiz WE; Luan T; Clark AF; McDowell CM
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1811-1823. PubMed ID: 28346614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-angle glaucoma: therapeutically targeting the extracellular matrix of the conventional outflow pathway.
    O'Callaghan J; Cassidy PS; Humphries P
    Expert Opin Ther Targets; 2017 Nov; 21(11):1037-1050. PubMed ID: 28952395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium 4-Phenylbutyrate Reduces Ocular Hypertension by Degrading Extracellular Matrix Deposition via Activation of MMP9.
    Maddineni P; Kasetti RB; Kodati B; Yacoub S; Zode GS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
    Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinases and Glaucoma Treatment.
    Weinreb RN; Robinson MR; Dibas M; Stamer WD
    J Ocul Pharmacol Ther; 2020 May; 36(4):208-228. PubMed ID: 32233938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Missense Extracellular Matrix Gene Variants in a Large Glaucoma Pedigree and Investigation of the N700S Thrombospondin-1 Variant in Normal and Glaucomatous Trabecular Meshwork Cells.
    Wirtz MK; Sykes R; Samples J; Edmunds B; Choi D; Keene DR; Tufa SF; Sun YY; Keller KE
    Curr Eye Res; 2022 Jan; 47(1):79-90. PubMed ID: 34143713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomechanical Rigidity and Quantitative Proteomics Analysis of Segmental Regions of the Trabecular Meshwork at Physiologic and Elevated Pressures.
    Vranka JA; Staverosky JA; Reddy AP; Wilmarth PA; David LL; Acott TS; Russell P; Raghunathan VK
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):246-259. PubMed ID: 29340639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
    Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
    Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Collagen Composition of the Trabecular Meshwork Results in Reduced Aqueous Humor Drainage and Elevated IOP in MMP-9 Null Mice.
    De Groef L; Andries L; Siwakoti A; Geeraerts E; Bollaerts I; Noterdaeme L; Etienne I; Papageorgiou AP; Stalmans I; Billen J; West-Mays JA; Moons L
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):5984-5995. PubMed ID: 27820954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.